Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,046 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term clinical benefits of a platelet glycoprotein IIb/IIIa receptor blocker, abciximab (ReoPro), in high-risk diabetic patients undergoing percutaneous coronary intervention.
Sim DS, Jeong MH, Kim W, Rhew JY, Yum JH, Kim JH, Cho JG, Ahn YK, Park JC, Ahn BH, Kim SH, Kang JC. Sim DS, et al. Among authors: kim w, kim sh, kim jh. Korean J Intern Med. 2003 Sep;18(3):129-37. doi: 10.3904/kjim.2003.18.3.129. Korean J Intern Med. 2003. PMID: 14619381 Free PMC article. Clinical Trial.
The use of low molecular weight heparin to predict clinical outcome in patients with unstable angina that had undergone percutaneous coronary intervention.
Hong YJ, Jeong MH, Lee SH, Park OY, Kim JH, Kim W, Rhew JY, Ahn YK, Cho JG, Park JC, Suh SP, Ahn BH, Kim SH, Kang JC. Hong YJ, et al. Among authors: kim w, kim sh, kim jh. Korean J Intern Med. 2003 Sep;18(3):167-73. doi: 10.3904/kjim.2003.18.3.167. Korean J Intern Med. 2003. PMID: 14619386 Free PMC article.
Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention.
Lim SY, Jeong MH, Bae EH, Kim W, Kim JH, Hong YJ, Park HW, Kang DG, Lee YS, Kim KH, Lee SH, Yun KH, Hong SN, Cho JG, Ahn YK, Park JC, Ahn BH, Kim SH, Kang JC. Lim SY, et al. Among authors: kim w, kim sh, kim kh, kim jh. Circ J. 2005 Feb;69(2):154-8. doi: 10.1253/circj.69.154. Circ J. 2005. PMID: 15671605 Free article.
Long-term clinical outcomes of platelet glycoprotein IIb/IIIa inhibitor combined with low molecular weight heparin in patients with acute coronary syndrome.
Kim JH, Jeong MH, Rhew JY, Lim JH, Yun KH, Kim KH, Kang DK, Hong SN, Lim SY, Lee SH, Lee YS, Hong YJ, Park HW, Kim W, Ahn YK, Moon Y, Cho JG, Park JC, Kang JC. Kim JH, et al. Among authors: kim w, kim kh. Circ J. 2005 Feb;69(2):159-64. doi: 10.1253/circj.69.159. Circ J. 2005. PMID: 15671606 Free article. Clinical Trial.
32,046 results
You have reached the last available page of results. Please see the User Guide for more information.